ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,441Medicare Part D Prescriptions Filled, Including Refills

Rank: 52 out of 663

$469K Total Retail Price of All Prescriptions

Rank: 81 out of 663

613 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
9% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 613 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

8% of this provider’s 613 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 9,358 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
SIMVASTATIN 689 655 1 1
LISINOPRIL 641 564 2 2
OMEPRAZOLE 440 392 3 4
ATENOLOL 330 311 4 10
ALENDRONATE SODIUM 297 284 5 15
METFORMIN HCL 281 235 6 9
AMLODIPINE BESYLATE 273 245 7 5
LEVOTHROID 241 226 8 19
PRAVASTATIN SODIUM 236 218 9 21
K-TAB 230 201 10 36
WARFARIN SODIUM 216 204 11 8
FUROSEMIDE 215 197 12 7
GLIPIZIDE 210 175 13 29
HYDROCHLOROTHIAZIDE 205 194 14 12
METOPROLOL TARTRATE 177 156 15 11
FLUOXETINE HCL 173 150 16 32
TERAZOSIN HCL 170 167 17 38
LEVOTHYROXINE SODIUM 169 159 18 3
OXYCODONE-ACETAMINOPHEN 167 134 S2 19 26
NOVOLIN N 163 139 20 44
ALLOPURINOL 148 148 21 28
FLUTICASONE PROPIONATE 142 136 22 27
HYDROCODONE-ACETAMINOPHEN 142 95 S3 22 6
LOSARTAN POTASSIUM 134 131 24 14
ATORVASTATIN CALCIUM 129 108 25 13
GABAPENTIN 128 97 26 20
LOVASTATIN 117 105 27 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 106 28 22
FAMOTIDINE 108 102 29 76
ZOSTAVAX 108 97 29 112
INSULIN SYRINGE 107 89 31 55
PROAIR HFA 94 81 32 33
ZOLPIDEM TARTRATE 93 69 33 16
RANITIDINE HCL 93 82 33 31
TRAMADOL HCL 92 83 35 17
PREDNISONE 88 85 36 39
TAMSULOSIN HCL 85 75 37 24
QVAR 82 80 38 91
CITALOPRAM HBR 80 71 39 18
SPIRONOLACTONE 78 74 40 58
TRAZODONE HCL 76 65 41 34
NOVOLIN R 73 61 42 106
DIGOXIN 68 68 43 50
OXYBUTYNIN CHLORIDE 67 65 44 99
ESTRADIOL 52 48 R 45 66
SERTRALINE HCL 52 51 45 35
SPIRIVA 51 46 47 62
TRIAMTERENE-HYDROCHLOROTHIAZID 50 50 48 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.